APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hospital-Acquired Infections Assays

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Hospital-Acquired Infections Assays Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 March 2026190 pages

Choose your research edition.

Industry ResearchHospital-Acquired Infections Assays Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Hospital-Acquired Infections Assays Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Hospital-Acquired Infections Assays Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hospital-Acquired Infections Assays Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Hospital-Acquired Infections Assays Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Hospital-Acquired Infections Assays market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Hospital-Acquired Infections Assays is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hospital-Acquired Infections Assays is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hospital-Acquired Infections Assays is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Hospital-Acquired Infections Assays is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hospital-Acquired Infections Assays include BIOMÉRIEUX, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthcare Private Limited, BD (Becton, Dickinson and Company), Bioscience, Inc., QIAGEN, Thermo Fisher Scientific Inc. and Meridian Bioscience, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Hospital-Acquired Infections Assays market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hospital-Acquired Infections Assays and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hospital-Acquired Infections Assays revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Hospital-Acquired Infections Assays market size, projected growth trends, production technologies, key applications, and end-use industries.

Hospital-Acquired Infections Assays Segment by Company

BIOMÉRIEUX

Abbott

F. Hoffmann-La Roche Ltd.

Siemens Healthcare Private Limited

BD (Becton, Dickinson and Company)

Bioscience, Inc.

QIAGEN

Thermo Fisher Scientific Inc.

Meridian Bioscience, Inc.

Hologic, Inc.

Hospital-Acquired Infections Assays Segment by Type

Blood Tests

Urinalysis

Hospital-Acquired Infections Assays Segment by Application

Urinary Tract Infections

Pneumonia

Surgical Site Infections

Bloodstream Infections

Other Hospital Infections

Hospital-Acquired Infections Assays Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hospital-Acquired Infections Assays market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hospital-Acquired Infections Assays and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hospital-Acquired Infections Assays.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Hospital-Acquired Infections Assays in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hospital-Acquired Infections Assays industry.

Chapter 3: Detailed analysis of Hospital-Acquired Infections Assays companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hospital-Acquired Infections Assaysrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Hospital-Acquired Infections Assays Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Blood Tests Table 3. Key Players of Urinalysis Table 4. Global Hospital-Acquired Infections Assays Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Urinary Tract Infections Table 6. Key Players of Pneumonia Table 7. Key Players of Surgical Site Infections Table 8. Key Players of Bloodstream Infections Table 9. Key Players of Other Hospital Infections Table 10. Global Hospital-Acquired Infections Assays Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Hospital-Acquired Infections Assays Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Hospital-Acquired Infections Assays Market Share by Region (2021-2026) Table 13. Global Hospital-Acquired Infections Assays Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Hospital-Acquired Infections Assays Market Share by Region (2027-2032) Table 15. Hospital-Acquired Infections Assays Industry Trends Table 16. Hospital-Acquired Infections Assays Industry Drivers Table 17. Hospital-Acquired Infections Assays Industry Opportunities and Challenges Table 18. Hospital-Acquired Infections Assays Industry Restraints Table 19. Global Hospital-Acquired Infections Assays Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Hospital-Acquired Infections Assays Revenue Market Share by Company (2021-2026) Table 21. Global Hospital-Acquired Infections Assays Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Hospital-Acquired Infections Assays Key Company Head Office and Area Served Table 23. Global Hospital-Acquired Infections Assays Company, Product Type & Application Table 24. Global Hospital-Acquired Infections Assays Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Hospital-Acquired Infections Assays by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Hospital-Acquired Infections Assays Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Hospital-Acquired Infections Assays Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Hospital-Acquired Infections Assays Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Hospital-Acquired Infections Assays Revenue Market Share by Type (2021-2026) Table 31. Global Hospital-Acquired Infections Assays Revenue Market Share by Type (2027-2032) Table 32. Global Hospital-Acquired Infections Assays Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Hospital-Acquired Infections Assays Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Hospital-Acquired Infections Assays Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Hospital-Acquired Infections Assays Revenue Market Share by Application (2021-2026) Table 36. Global Hospital-Acquired Infections Assays Revenue Market Share by Application (2027-2032) Table 37. BIOMÉRIEUX Company Information Table 38. BIOMÉRIEUX Business Overview Table 39. BIOMÉRIEUX Hospital-Acquired Infections Assays Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. BIOMÉRIEUX Hospital-Acquired Infections Assays Product Portfolio Table 41. BIOMÉRIEUX Recent Development Table 42. Abbott Company Information Table 43. Abbott Business Overview Table 44. Abbott Hospital-Acquired Infections Assays Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Abbott Hospital-Acquired Infections Assays Product Portfolio Table 46. Abbott Recent Development Table 47. F. Hoffmann-La Roche Ltd. Company Information Table 48. F. Hoffmann-La Roche Ltd. Business Overview Table 49. F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Product Portfolio Table 51. F. Hoffmann-La Roche Ltd. Recent Development Table 52. Siemens Healthcare Private Limited Company Information Table 53. Siemens Healthcare Private Limited Business Overview Table 54. Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Product Portfolio Table 56. Siemens Healthcare Private Limited Recent Development Table 57. BD (Becton, Dickinson and Company) Company Information Table 58. BD (Becton, Dickinson and Company) Business Overview Table 59. BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Product Portfolio Table 61. BD (Becton, Dickinson and Company) Recent Development Table 62. Bioscience, Inc. Company Information Table 63. Bioscience, Inc. Business Overview Table 64. Bioscience, Inc. Hospital-Acquired Infections Assays Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Bioscience, Inc. Hospital-Acquired Infections Assays Product Portfolio Table 66. Bioscience, Inc. Recent Development Table 67. QIAGEN Company Information Table 68. QIAGEN Business Overview Table 69. QIAGEN Hospital-Acquired Infections Assays Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. QIAGEN Hospital-Acquired Infections Assays Product Portfolio Table 71. QIAGEN Recent Development Table 72. Thermo Fisher Scientific Inc. Company Information Table 73. Thermo Fisher Scientific Inc. Business Overview Table 74. Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Product Portfolio Table 76. Thermo Fisher Scientific Inc. Recent Development Table 77. Meridian Bioscience, Inc. Company Information Table 78. Meridian Bioscience, Inc. Business Overview Table 79. Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Product Portfolio Table 81. Meridian Bioscience, Inc. Recent Development Table 82. Hologic, Inc. Company Information Table 83. Hologic, Inc. Business Overview Table 84. Hologic, Inc. Hospital-Acquired Infections Assays Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Hologic, Inc. Hospital-Acquired Infections Assays Product Portfolio Table 86. Hologic, Inc. Recent Development Table 87. North America Hospital-Acquired Infections Assays Market Size by Type (2021-2026) & (US$ Million) Table 88. North America Hospital-Acquired Infections Assays Market Size by Type (2027-2032) & (US$ Million) Table 89. North America Hospital-Acquired Infections Assays Market Size by Application (2021-2026) & (US$ Million) Table 90. North America Hospital-Acquired Infections Assays Market Size by Application (2027-2032) & (US$ Million) Table 91. North America Hospital-Acquired Infections Assays Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. North America Hospital-Acquired Infections Assays Market Size by Country (2021-2026) Table 93. North America Hospital-Acquired Infections Assays Market Size by Country (2027-2032) Table 94. Europe Hospital-Acquired Infections Assays Market Size by Type (2021-2026) & (US$ Million) Table 95. Europe Hospital-Acquired Infections Assays Market Size by Type (2027-2032) & (US$ Million) Table 96. Europe Hospital-Acquired Infections Assays Market Size by Application (2021-2026) & (US$ Million) Table 97. Europe Hospital-Acquired Infections Assays Market Size by Application (2027-2032) & (US$ Million) Table 98. Europe Hospital-Acquired Infections Assays Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Europe Hospital-Acquired Infections Assays Market Size by Country (2021-2026) Table 100. Europe Hospital-Acquired Infections Assays Market Size by Country (2027-2032) Table 101. China Hospital-Acquired Infections Assays Market Size by Type (2021-2026) & (US$ Million) Table 102. China Hospital-Acquired Infections Assays Market Size by Type (2027-2032) & (US$ Million) Table 103. China Hospital-Acquired Infections Assays Market Size by Application (2021-2026) & (US$ Million) Table 104. China Hospital-Acquired Infections Assays Market Size by Application (2027-2032) & (US$ Million) Table 105. Asia Hospital-Acquired Infections Assays Market Size by Type (2021-2026) & (US$ Million) Table 106. Asia Hospital-Acquired Infections Assays Market Size by Type (2027-2032) & (US$ Million) Table 107. Asia Hospital-Acquired Infections Assays Market Size by Application (2021-2026) & (US$ Million) Table 108. Asia Hospital-Acquired Infections Assays Market Size by Application (2027-2032) & (US$ Million) Table 109. Asia Hospital-Acquired Infections Assays Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Asia Hospital-Acquired Infections Assays Market Size by Country (2021-2026) Table 111. Asia Hospital-Acquired Infections Assays Market Size by Country (2027-2032) Table 112. South America, Middle East & Africa Hospital-Acquired Infections Assays Market Size by Type (2021-2026) & (US$ Million) Table 113. South America, Middle East & Africa Hospital-Acquired Infections Assays Market Size by Type (2027-2032) & (US$ Million) Table 114. South America, Middle East & Africa Hospital-Acquired Infections Assays Market Size by Application (2021-2026) & (US$ Million) Table 115. South America, Middle East & Africa Hospital-Acquired Infections Assays Market Size by Application (2027-2032) & (US$ Million) Table 116. South America, Middle East & Africa Hospital-Acquired Infections Assays Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. South America, Middle East & Africa Hospital-Acquired Infections Assays Market Size by Country (2021-2026) Table 118. South America, Middle East & Africa Hospital-Acquired Infections Assays Market Size by Country (2027-2032) Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Hospital-Acquired Infections Assays Product Image Figure 2. Global Hospital-Acquired Infections Assays Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Hospital-Acquired Infections Assays Market Share by Type: 2025 VS 2032 Figure 4. Blood Tests Image Figure 5. Urinalysis Image Figure 6. Global Hospital-Acquired Infections Assays Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Hospital-Acquired Infections Assays Market Share by Application: 2025 VS 2032 Figure 8. Urinary Tract Infections Image Figure 9. Pneumonia Image Figure 10. Surgical Site Infections Image Figure 11. Bloodstream Infections Image Figure 12. Other Hospital Infections Image Figure 13. Global Hospital-Acquired Infections Assays Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 15. Global Hospital-Acquired Infections Assays Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Hospital-Acquired Infections Assays Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Hospital-Acquired Infections Assays Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Hospital-Acquired Infections Assays Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Hospital-Acquired Infections Assays Revenue Market Share by Type (2021-2032) Figure 22. Global Hospital-Acquired Infections Assays Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Hospital-Acquired Infections Assays Revenue Market Share by Application (2021-2032) Figure 24. North America Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 25. North America Hospital-Acquired Infections Assays Market Share by Type (2021-2032) Figure 26. North America Hospital-Acquired Infections Assays Market Share by Application (2021-2032) Figure 27. North America Hospital-Acquired Infections Assays Market Share by Country (2021-2032) Figure 28. United States Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 29. Canada Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 31. Europe Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 32. Europe Hospital-Acquired Infections Assays Market Share by Type (2021-2032) Figure 33. Europe Hospital-Acquired Infections Assays Market Share by Application (2021-2032) Figure 34. Europe Hospital-Acquired Infections Assays Market Share by Country (2021-2032) Figure 35. Germany Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 36. France Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 38. Italy Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 39. Russia Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 41. China Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 42. China Hospital-Acquired Infections Assays Market Share by Type (2021-2032) Figure 43. China Hospital-Acquired Infections Assays Market Share by Application (2021-2032) Figure 44. Asia Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 45. Asia Hospital-Acquired Infections Assays Market Share by Type (2021-2032) Figure 46. Asia Hospital-Acquired Infections Assays Market Share by Application (2021-2032) Figure 47. Asia Hospital-Acquired Infections Assays Market Share by Country (2021-2032) Figure 48. Japan Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 52. India Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 53. Australia Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Hospital-Acquired Infections Assays Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Hospital-Acquired Infections Assays Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Hospital-Acquired Infections Assays Market Share by Country (2021-2032) Figure 58. Brazil Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 63. UAE Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 65. Chile Hospital-Acquired Infections Assays Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Tests
  • Urinalysis
Applications
  • Urinary Tract Infections
  • Pneumonia
  • Surgical Site Infections
  • Bloodstream Infections
  • Other Hospital Infections
Companies covered
  • BIOMÉRIEUX
  • Abbott
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthcare Private Limited
  • BD (Becton, Dickinson and Company)
  • Bioscience, Inc.
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Meridian Bioscience, Inc.
  • Hologic, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Hospital-Acquired Infections Assays Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Blood Tests
  5. 1.2.3 Urinalysis
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Hospital-Acquired Infections Assays Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Urinary Tract Infections
  9. 1.3.3 Pneumonia
  10. 1.3.4 Surgical Site Infections
  11. 1.3.5 Bloodstream Infections
  12. 1.3.6 Other Hospital Infections
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Hospital-Acquired Infections Assays Growth Trends by Region
  15. 1.5.1 Global Hospital-Acquired Infections Assays Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Hospital-Acquired Infections Assays Market Size by Region (2021-2026)
  17. 1.5.3 Hospital-Acquired Infections Assays Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Hospital-Acquired Infections Assays Market Dynamics
  1. 2.1 Hospital-Acquired Infections Assays Industry Trends
  2. 2.2 Hospital-Acquired Infections Assays Industry Drivers
  3. 2.3 Hospital-Acquired Infections Assays Industry Opportunities and Challenges
  4. 2.4 Hospital-Acquired Infections Assays Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Hospital-Acquired Infections Assays Revenue by Company (2021-2026)
  2. 3.2 Global Hospital-Acquired Infections Assays Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Hospital-Acquired Infections Assays Key Company Head office and Area Served
  4. 3.4 Global Hospital-Acquired Infections Assays Company, Product Type & Application
  5. 3.5 Global Hospital-Acquired Infections Assays Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Hospital-Acquired Infections Assays Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Hospital-Acquired Infections Assays Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Hospital-Acquired Infections Assays Tier 1, Tier 2, and Tier 3
4 Hospital-Acquired Infections Assays Market by Type
  1. 4.1 Global Hospital-Acquired Infections Assays Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Hospital-Acquired Infections Assays Market Size by Type (2021-2032)
  3. 4.3 Global Hospital-Acquired Infections Assays Market Size Share by Type (2021-2032)
5 Hospital-Acquired Infections Assays Market by Application
  1. 5.1 Global Hospital-Acquired Infections Assays Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Hospital-Acquired Infections Assays Market Size by Application (2021-2032)
  3. 5.3 Global Hospital-Acquired Infections Assays Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 BIOMÉRIEUX
  2. 6.1.1 BIOMÉRIEUX Company Information
  3. 6.1.2 BIOMÉRIEUX Business Overview
  4. 6.1.3 BIOMÉRIEUX Hospital-Acquired Infections Assays Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 BIOMÉRIEUX Hospital-Acquired Infections Assays Product Portfolio
  6. 6.1.5 BIOMÉRIEUX Recent Developments
  7. 6.2 Abbott
  8. 6.2.1 Abbott Company Information
  9. 6.2.2 Abbott Business Overview
  10. 6.2.3 Abbott Hospital-Acquired Infections Assays Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Abbott Hospital-Acquired Infections Assays Product Portfolio
  12. 6.2.5 Abbott Recent Developments
  13. 6.3 F. Hoffmann-La Roche Ltd.
  14. 6.3.1 F. Hoffmann-La Roche Ltd. Company Information
  15. 6.3.2 F. Hoffmann-La Roche Ltd. Business Overview
  16. 6.3.3 F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Product Portfolio
  18. 6.3.5 F. Hoffmann-La Roche Ltd. Recent Developments
  19. 6.4 Siemens Healthcare Private Limited
  20. 6.4.1 Siemens Healthcare Private Limited Company Information
  21. 6.4.2 Siemens Healthcare Private Limited Business Overview
  22. 6.4.3 Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Product Portfolio
  24. 6.4.5 Siemens Healthcare Private Limited Recent Developments
  25. 6.5 BD (Becton, Dickinson and Company)
  26. 6.5.1 BD (Becton, Dickinson and Company) Company Information
  27. 6.5.2 BD (Becton, Dickinson and Company) Business Overview
  28. 6.5.3 BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Product Portfolio
  30. 6.5.5 BD (Becton, Dickinson and Company) Recent Developments
  31. 6.6 Bioscience, Inc.
  32. 6.6.1 Bioscience, Inc. Company Information
  33. 6.6.2 Bioscience, Inc. Business Overview
  34. 6.6.3 Bioscience, Inc. Hospital-Acquired Infections Assays Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Bioscience, Inc. Hospital-Acquired Infections Assays Product Portfolio
  36. 6.6.5 Bioscience, Inc. Recent Developments
  37. 6.7 QIAGEN
  38. 6.7.1 QIAGEN Company Information
  39. 6.7.2 QIAGEN Business Overview
  40. 6.7.3 QIAGEN Hospital-Acquired Infections Assays Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 QIAGEN Hospital-Acquired Infections Assays Product Portfolio
  42. 6.7.5 QIAGEN Recent Developments
  43. 6.8 Thermo Fisher Scientific Inc.
  44. 6.8.1 Thermo Fisher Scientific Inc. Company Information
  45. 6.8.2 Thermo Fisher Scientific Inc. Business Overview
  46. 6.8.3 Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Product Portfolio
  48. 6.8.5 Thermo Fisher Scientific Inc. Recent Developments
  49. 6.9 Meridian Bioscience, Inc.
  50. 6.9.1 Meridian Bioscience, Inc. Company Information
  51. 6.9.2 Meridian Bioscience, Inc. Business Overview
  52. 6.9.3 Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Product Portfolio
  54. 6.9.5 Meridian Bioscience, Inc. Recent Developments
  55. 6.10 Hologic, Inc.
  56. 6.10.1 Hologic, Inc. Company Information
  57. 6.10.2 Hologic, Inc. Business Overview
  58. 6.10.3 Hologic, Inc. Hospital-Acquired Infections Assays Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Hologic, Inc. Hospital-Acquired Infections Assays Product Portfolio
  60. 6.10.5 Hologic, Inc. Recent Developments
7 North America
  1. 7.1 North America Hospital-Acquired Infections Assays Market Size (2021-2032)
  2. 7.2 North America Hospital-Acquired Infections Assays Market Size by Type
  3. 7.2.1 North America Hospital-Acquired Infections Assays Market Size by Type (2021-2026)
  4. 7.2.2 North America Hospital-Acquired Infections Assays Market Size by Type (2027-2032)
  5. 7.2.3 North America Hospital-Acquired Infections Assays Market Share by Type (2021-2032)
  6. 7.3 North America Hospital-Acquired Infections Assays Market Size by Application
  7. 7.3.1 North America Hospital-Acquired Infections Assays Market Size by Application (2021-2026)
  8. 7.3.2 North America Hospital-Acquired Infections Assays Market Size by Application (2027-2032)
  9. 7.3.3 North America Hospital-Acquired Infections Assays Market Share by Application (2021-2032)
  10. 7.4 North America Hospital-Acquired Infections Assays Market Size by Country
  11. 7.4.1 North America Hospital-Acquired Infections Assays Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Hospital-Acquired Infections Assays Market Size by Country (2021-2026)
  13. 7.4.3 North America Hospital-Acquired Infections Assays Market Size by Country (2027-2032)
  14. 7.4.4 North America Hospital-Acquired Infections Assays Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Hospital-Acquired Infections Assays Market Size (2021-2032)
  2. 8.2 Europe Hospital-Acquired Infections Assays Market Size by Type
  3. 8.2.1 Europe Hospital-Acquired Infections Assays Market Size by Type (2021-2026)
  4. 8.2.2 Europe Hospital-Acquired Infections Assays Market Size by Type (2027-2032)
  5. 8.2.3 Europe Hospital-Acquired Infections Assays Market Share by Type (2021-2032)
  6. 8.3 Europe Hospital-Acquired Infections Assays Market Size by Application
  7. 8.3.1 Europe Hospital-Acquired Infections Assays Market Size by Application (2021-2026)
  8. 8.3.2 Europe Hospital-Acquired Infections Assays Market Size by Application (2027-2032)
  9. 8.3.3 Europe Hospital-Acquired Infections Assays Market Share by Application (2021-2032)
  10. 8.4 Europe Hospital-Acquired Infections Assays Market Size by Country
  11. 8.4.1 Europe Hospital-Acquired Infections Assays Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Hospital-Acquired Infections Assays Market Size by Country (2021-2026)
  13. 8.4.3 Europe Hospital-Acquired Infections Assays Market Size by Country (2027-2032)
  14. 8.4.4 Europe Hospital-Acquired Infections Assays Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Hospital-Acquired Infections Assays Market Size (2021-2032)
  2. 9.2 China Hospital-Acquired Infections Assays Market Size by Type
  3. 9.2.1 China Hospital-Acquired Infections Assays Market Size by Type (2021-2026)
  4. 9.2.2 China Hospital-Acquired Infections Assays Market Size by Type (2027-2032)
  5. 9.2.3 China Hospital-Acquired Infections Assays Market Share by Type (2021-2032)
  6. 9.3 China Hospital-Acquired Infections Assays Market Size by Application
  7. 9.3.1 China Hospital-Acquired Infections Assays Market Size by Application (2021-2026)
  8. 9.3.2 China Hospital-Acquired Infections Assays Market Size by Application (2027-2032)
  9. 9.3.3 China Hospital-Acquired Infections Assays Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Hospital-Acquired Infections Assays Market Size (2021-2032)
  2. 10.2 Asia Hospital-Acquired Infections Assays Market Size by Type
  3. 10.2.1 Asia Hospital-Acquired Infections Assays Market Size by Type (2021-2026)
  4. 10.2.2 Asia Hospital-Acquired Infections Assays Market Size by Type (2027-2032)
  5. 10.2.3 Asia Hospital-Acquired Infections Assays Market Share by Type (2021-2032)
  6. 10.3 Asia Hospital-Acquired Infections Assays Market Size by Application
  7. 10.3.1 Asia Hospital-Acquired Infections Assays Market Size by Application (2021-2026)
  8. 10.3.2 Asia Hospital-Acquired Infections Assays Market Size by Application (2027-2032)
  9. 10.3.3 Asia Hospital-Acquired Infections Assays Market Share by Application (2021-2032)
  10. 10.4 Asia Hospital-Acquired Infections Assays Market Size by Country
  11. 10.4.1 Asia Hospital-Acquired Infections Assays Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Hospital-Acquired Infections Assays Market Size by Country (2021-2026)
  13. 10.4.3 Asia Hospital-Acquired Infections Assays Market Size by Country (2027-2032)
  14. 10.4.4 Asia Hospital-Acquired Infections Assays Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Hospital-Acquired Infections Assays Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Hospital-Acquired Infections Assays Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Hospital-Acquired Infections Assays Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Hospital-Acquired Infections Assays Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Hospital-Acquired Infections Assays Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Hospital-Acquired Infections Assays Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Hospital-Acquired Infections Assays Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Hospital-Acquired Infections Assays Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Hospital-Acquired Infections Assays Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Hospital-Acquired Infections Assays Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Hospital-Acquired Infections Assays Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Hospital-Acquired Infections Assays Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Hospital-Acquired Infections Assays Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Hospital-Acquired Infections Assays Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst